DIA会员及用户请点击登录

登录

忘记用户 ID? or 忘记密码?

Not a Member?

创建账户并加入。

Washington Court Hotel

2013 年 09 月 25 日 8:00 上午 - 2013 年 09 月 27 日 5:00 下午

525 New Jersey Avenue NW, Washington, DC 20001

DIA/FDA Oligonucleotide-based Therapeutics Conference

Session Chair(s)

James V. McArdle, PHD

James V. McArdle, PHD

President

McArdle & Associates LLC, United States

Speaker(s)

H. Gregg  Claycamp, PHD, MS

ICH Q9 Quality Risk Management: Perspective and Examples

H. Gregg Claycamp, PHD, MS

FDA, United States

Senior Scientist for Risk Analysis and Decision Analysis, ONADE, CVM

Paul  Van Norman

Applications of Risk Assessment in the Manufacturing Development Cycle

Paul Van Norman

NITTO DENKO Avecia, Inc., United States

Director, Manufacturing Operations

Paul  Van Norman

Paul Van Norman

NITTO DENKO Avecia, Inc., United States

Director, Manufacturing Operations

H. Gregg  Claycamp, PHD, MS

Panelist

H. Gregg Claycamp, PHD, MS

FDA, United States

Senior Scientist for Risk Analysis and Decision Analysis, ONADE, CVM

Mohan K. Sapru, PHD, MS

Panelist

Mohan K. Sapru, PHD, MS

FDA, United States

CMC Lead, Office of Pharmaceutical Quality, CDER

Susann  Rosmus

Panelist

Susann Rosmus

Biospring GmbH, Germany

Head of QM

获得信息并保持参与

不要错失任何机会——请加入我们的邮件列表,了解DIA的观点和事件。